News by subject: HEALTH

Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunotherapy platform designed to restore innate immune function, is pleased to announce it has received Health Canada clearance...

Profound Medical Corp. ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced that updated results from the TACT...

Dr. Pang Yiu-kai, Chairman of the Hong Kong Tourism Board (HKTB), welcomed the Government's announcement on September 23 (HKT) on the new "0+3" arrangements from September 26 for inbound travellers from overseas and Taiwan through Hong Kong...

The RTOERO Foundation is now accepting letters of intent for grants of $10,000 to $50,000 to support projects that aim to improve seniors' health and wellness, promote social engagement for older adults and/or pursue innovative research in the field...

Titan Medical Inc. , a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced the publication of international patent application...

Optimi Health Corp. (FRA: 8BN) ("Optimi" or the "Company"), a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP grade psilocybin and other psychedelic substances, most notably MDMA, is pleased to announce that...

Medicenna Therapeutics Corp. ("Medicenna" or "the...

Tilray Brands, Inc. ("Tilray" or the "Company") , a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that FL Group S.R.L. ("FL Group"), a division of Tilray Medical in...

FOUR20 announces the opening of its first Ontario location with the retail store based in Kitchener, a city in southeastern Ontario. The opening is the first step in FOUR20's expansion into the Ontario market with a focus on providing accessible...

The BC Cancer Foundation has today announced the launch of the historic $500 million Beyond Belief fundraising campaign to advance cancer research and enhance care across British Columbia. In...

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that Herriot Tabuteau, MD, Axsome's Chief Executive Officer, will...

Fennec Pharmaceuticals Inc. , a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved PEDMARK® (sodium thiosulfate injection) to reduce the risk of...

Aurora Spine Corporation ("Aurora Spine" or the "Company") , a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the Lytham Partners Fall 2022 Investor...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the...

via InvestorWire -- Following a three-year hiatus, Lift&Co. Expo will return to Vancouver Convention Centre on January 12-14, 2023. The upcoming British Columbia dates are the first on the west coast for Canada's number-one cannabis conference and...

Next Generation Manufacturing Canada (NGen), the industry-led organization behind Canada's Global Innovation Cluster for Advanced Manufacturing, has announced a $10.5 million contribution to a $34.8 million project led by OmniaBio Inc. (Hamilton) and...

Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization therapies. The ENIS-3 trial has achieved >33% of target enrollment (948 patients). The independent...

AVRICORE HEALTH INC. (the "Company" or "AVCR") was honoured to join the Globe and Mail's recent Health Care Innovation event, featuring leaders from various corners of the sector, including Company CEO, Hector Bremner. "With about 40% of patients...

On Friday, September 16, Medexus Pharmaceuticals (Medexus) was informed by...

Antimicrobial resistance (AMR) is a global scale threat to human life and economic prosperity. If left unchecked, it has the potential to set medicine back 100 years, jeopardize 10 million lives worldwide and impose enormous economic burdens on...

Codex DNA, Inc. , a pioneer in automated benchtop synthetic biology systems, today announced commercial release and first shipment of the BioXptm 9600 system, a next-generation high throughput platform designed to revolutionize synthetic biology...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") a clinical stage pharmaceutical development company is pleased to announce that it has decided to advance its investigation of NP-120 (Ifenprodil) for IPF with cough as its key...

The innocent lives lost as a result of impaired driving will be honoured this Saturday as their families and friends gather with MADD Canada and special guests for a ceremony of remembrance at the Alberta Memorial Monument for Victims of Impaired...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on the Company's Phase I/II...

September 16, 2022 Global consensus data recommends the use of intravascular ultrasound (IVUS) in many peripheral vascular disease (PVD) proceduresPhilips Engagement Hub at TCT to feature a range of physician-led discussions, in-depth symposia,...

September 15, 2022 Philips FetView will offer real-time, off cart remote patient management with access to data from any ultrasound system, anytime and anywhere, to enhance diagnostic confidence for physicians and provide peace of mind for...

The following is a statement by the Ontario Health Coalition: What: Leading advocates for elderly patients are responding to the Health Minister's statement about the regulations. The Ford government made a statement today regarding the regulations...

TILT Holdings Inc. ("TILT" or the "Company") (NEO: TILT) , a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced the Massachusetts...

The following is a statement by the Ontario Health Coalition: What: Leading advocates for elderly patients are responding to the Health Minister's statement about the regulations. The Ford government made a statement today regarding the regulations...

Grow Up Conference and Expo ("Grow Up") held the 3rd Annual Grow Up Industry Awards Gala on Monday, September 12th at the Niagara Falls Convention Centre. Cannabis professionals were nominated for their efforts, knowledge, and accomplishments in the...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that it has filed an amended protocol to the U.S....

The Sabin Vaccine Institute today announced it is receiving an additional $21.8 million under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and...

Small Pharma Inc. (the "Company" or "Small Pharma"), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, today announced that it has entered into an automatic share purchase plan (the "ASPP")...

September 13, 2022 Philips Foundation and RAD-AID International leverage Philips' expertise in mobile ultrasound services to improve access to virtual care in hard-to-reach areasNew partnership sets up intensive program in 10 countries to train a...

22nd Century Group, Inc. , a leading agricultural...

AccuStem Sciences, Inc. , a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced today that the US Patent and Trademark Office has issued a new patent, No. 11,441,191, further strengthening the...

For more-than 30 years, the Breast Cancer Society of Canada has been the leading organization for breast cancer research. Today, the organization has rebranded to become Breast Cancer Canada, signaling a renewal in their commitment to research-driven...

Acasti Pharma Inc. ("Acasti" or the "Company") , today announces the initiation of its planned pharmacokinetic (PK) bridging study to evaluate the comparative bioavailability, pharmacokinetics, and safety of its oral betamethasone spray, GTX-102,...

Medicenna Therapeutics Corp. ("Medicenna" or "the Company") , a clinical stage immuno-oncology company, today announced that it has entered into a clinical trial collaboration and supply agreement with Merck (known as MSD outside the United States...

Rubius Therapeutics, Inc. , a biopharmaceutical company that...

ProMIS Neurosciences, Inc. , a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, implicated in the development of neurodegenerative diseases, announced today...

Hearing aid innovator Signia is launching My WellBeing, a new app-based toolset designed to improve the hearing health of Signia hearing aid wearers by encouraging a more consistent and prolonged use of their hearing devices. The tool, available...

The Broad Institute of MIT and Harvard (Broad), a leader in advancing human health through genomic research, and Datavant, the leader in helping organizations securely connect health data, today announce a long-term collaboration to scale...

Theratechnologies Inc. ("Theratechnologies"...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") a clinical stage pharmaceutical development company is pleased to announce that it has received approval to conduct a Phase 1 clinical study of an intravenous formulation ("IVF") of...

As world leaders gather for the United Nations General Assembly, the Open Society Foundations is calling for bold steps to address critical worldwide crises, including: A global rescue plan that sees higher-income countries committing 2% of...

InMed Pharmaceuticals Inc. ("InMed" or the "Company") , a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announces an update on its research/development and commercial activities. Eric A....

IntelGenx Corp.  (the "Company" or "IntelGenx") today announced that patient enrollment in the ongoing Montelukast VersaFilm® Phase 2a ("BUENA") clinical trial in patients with mild to moderate Alzheimer's Disease ("AD") has reached the halfway...

Excellence Canada is collaborating with Merv Gilbert, Director of Vancouver Psych Safety Consulting, and Graham Lowe, President of the Graham Lowe Group? two of Canada's leading experts on healthy workplaces? to offer employers the Psychological...

LOVE Pharma , an international sexual health and wellness company, has made a strategic investment in Starton Therapeutics Inc., a New Jersey based clinical stage biotechnology company focused on transforming standard of care therapies in oncology....